The effect of the  -receptor blockade (propranolol) on the endocrine and exocrine pancreatic function in man after the administration of intestinal hormones (secretion and cholecystokinin-pancreozymin).
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D002766:Cholecystokinin / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D008297:Male; D010179:Pancreas / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology*; D012633:Secretin / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D012633:Secretin; D002766:Cholecystokinin; D011433:Propranolol